- Filed
- Feb 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $1.49B |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $971M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.13B |
| Current Assets | FY 2024 · Dec 31, 2023 | $3.15B |
| Total Assets | FY 2024 · Dec 31, 2023 | $6.65B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 242.16M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $947M |
| Capex | FY 2024 · Dec 31, 2022 | $115M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $4.5B |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$0.42 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$0.42 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $498M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $498M |
| Net Income | FY 2024 · Dec 31, 2022 | −$101M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$93M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $1.59B |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $367M |
| Revenue | FY 2024 · Dec 31, 2022 | $1.96B |
| Stockholders Equity restated | FY 2024 · Dec 31, 2021 | $5.34B |